The corticosteroid dose-response curve in asthma and how to identify patients for adjunctive and alternate therapies

References

• Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995; 332: 868–75.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol 1998; 102: 531–8.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Vermiere PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Hespir J 2000; 16: 802–7.
   PubMed Web of Science ®Google Scholar
• Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194–200.
   PubMed Web of Science ®Google Scholar
• Lange P, Ulrik CS, Vestbo J. Mortality in adults with self reported asthma. Copenhagen City Heart Study Group. Lancet 1996; 347: 1285–9.
   PubMed Web of Science ®Google Scholar
• Huovinen E, Kaprio J, Vesterinen E, Koskenvuo M. Mortality of adults with asthma: a prospective cohort study. Thorax 1997; 52: 49–54.
   PubMed Web of Science ®Google Scholar
• Busse W, Elias J, Sheppard D, Banks-Schlegel S. Airway remodeling and repair. Am J Respir Crit Care Med 1999; 160: 1035–42.
   PubMed Web of Science ®Google Scholar
• Sont JK, Willems LNA, Bel EH et al. Clinical control and histopathological outcome of asthma when using airway hyperresponsiveness as an additional guide to long term treatment. Am J Respir Crit Care Med 1998; 159: 1043–51.
   Web of Science ®Google Scholar
• Turner MO, Taylor D, Bennett R, Fitzgerald JM. A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med 1998; 157: 540–6.
   PubMed Web of Science ®Google Scholar
• Green RH, Brightling CE, McKenna S et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715–21.
   PubMed Web of Science ®Google Scholar
• Lang MJ, Leung DY, White CW. Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children. Ann Allergy Asthma Immunol 1999; 82: 161–4.
   PubMed Web of Science ®Google Scholar
• Kharitonov SA, Barnes PJ, O'Connor B. Reduction in exhaled nitric oxide after a single dose of nebulised budesonide in patients with asthma. Am J Resp Crit Care Med 1996; 153: A799.
   Google Scholar
• Stempel DA, Fuhlbrigge AL. Defining the responder in asthma therapy. J Allergy Clin Immunol 2005; 115: 466–9.
   PubMed Web of Science ®Google Scholar
• Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, et al. Characterization of within-subject response to fluticasone and montelukast in childhood asthma. A study for the Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. J Clin Allergy Immunol 2005; 115: 233–42.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Boushey HA, Bousquet J, et al. GOAL Investigators Group. Am J Respir Crit Care Med 2004; 170: 836–84.
   PubMed Web of Science ®Google Scholar
• Boushey HA, Boushey HA, Sorkness CA, King TS et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005; 352: 1519–28.
   PubMed Web of Science ®Google Scholar
• Price DB, Hernandez D, Magyar P, et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003; 58: 211–6.
   PubMed Web of Science ®Google Scholar
• Ostrom NK, Decotiis BA, Lincourt WR. Comparative efficacy and safety of low-dose fluticasone propionate and Montelukast in children with persistent asthma. J Pediatr 2005; 147: 213–20.
   PubMed Web of Science ®Google Scholar
• Sin DD, Man J, Sharpe H, Gan WQ, Man SF. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. JAMA 2004; 292: 367–76.
   PubMed Web of Science ®Google Scholar
• Powell H, Gibson PG. Initial starting dose of inhaled corticosteroids in adults with asthma: a systematic review. Thorax 2004; 59: 1041–5.
   PubMed Web of Science ®Google Scholar
• Ayres JG, Bateman ED, Lundback B, Harris TAJ. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. Eur Resp J 1995; 8: 579–86.
   PubMed Web of Science ®Google Scholar
• Currie GP, Fowler SJ, Lipworth BJ. Dose response of inhaled corticosteroids on bronchial hyperresponsiveness: a meta-analysis. Ann Allergy Asthma Immunol 2003; 90: 194–8.
   PubMed Web of Science ®Google Scholar
• Masoli M, Weatherall M, Holt S, Beasley R. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax 2005; 60: 730–4.
   PubMed Web of Science ®Google Scholar
• Davies B, Brooks G, Devoy M. The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies. Respir Med 1998; 92: 256–63.
   PubMed Web of Science ®Google Scholar